Rapid decrease in high titer of factor VIII inhibitors upon immunosuppressive treatment in severe postpartum acquired hemophilia A

被引:0
作者
Pejsa, V
Grgurevic, I
Kusec, R
Gacina, P
机构
[1] Univ Zagreb, Dubrava Univ Hosp, Div Hematol, Dept Internal Med, Zagreb 10000, Croatia
[2] Univ Zagreb, Dubrava Univ Hosp, Div Hematol, Dept Internal Med, Zagreb, Croatia
[3] Univ Zagreb, Merkur Univ Hosp, Dept Internal Med, Lab Mol Diagnost, Zagreb, Croatia
[4] Univ Zagreb, Merkur Univ Hosp, Div Hematol, Zagreb, Croatia
[5] Univ Zagreb, Merkur Univ Hosp, Inst Clin Chem, Zagreb, Croatia
[6] Univ Zagreb, Sisters Mercy Univ Hosp, Dept Internal Med, Div Hematol, Zagreb, Croatia
关键词
autoantibodies; hemophilia A; factor VIII; postpartum hemorrhage;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 25-year-old woman was diagnosed with acquired herriophilia caused by factor VIII (FVIII) inhibitors two months after normal delivery of her first child. She presented with severe spontaneous bleeding in the right forearm and distal part of the right leg. After venipuncture for diagnostic purposes, severe hematoma developed, affecting the whole left arm and shoulder. The diagnosis of acquired hemophilia was confirmed by the presence of FVIII inhibitors (Bethesda units=76), low activity of factor VIII (5%), and prolonged activated partial thromboplastin time (APTT = 89 s). The treatment with fresh frozen plasma, cryoprecipitate, red blood cells concentrate, methylprednisolone (3 mg/kg/day for 8 days, then I mg/kg/day), and cyclophosphamide (150 mg/day for 5 days, then 100 mg/day) was followed by the regression of hematomas and normalization of APTT and FVIII activity. The titer of FVIII inhibitors rapidly decreased and total disappearance of antibodies was achieved after 15 days. To the best of our knowledge, this is the shortest time to the disappearance of inhibitors to FVIII in postpartum acquired hemophilia ever reported. Transient reappearance of inhibitors occurred 10 months later and also promptly reacted to the same therapy. In the follow-up period of 4 years, the patient had two more pregnancies with no clinical and laboratory signs of illness recurrence. This case indicates important role of immunosuppressive therapy, which can rapidly induce a remission of this rare condition and be life-saving if introduced early in the course of illness and in doses higher than usually recommended.
引用
收藏
页码:213 / 216
页数:4
相关论文
共 23 条
[1]  
BLOOM AL, 1992, HAEMOSTASIS, V22, P268
[2]  
COLLER BS, 1981, BLOOD, V58, P619
[3]  
FANTL P, 1946, Med J Aust, V2, P125
[4]   Acquired high-titer factor VIII inhibitor:: fatal bleeding despite multimodal treatment including rituximab preceded by multiple plasmaphereses [J].
Fischer, KG ;
Deschler, B ;
Lübbert, M .
BLOOD, 2003, 101 (09) :3753-3754
[5]  
FULCHER CA, 1987, BLOOD, V69, P1475
[6]  
GREEN D, 1993, THROMB HAEMOSTASIS, V70, P753
[7]  
GREEN D, 1981, THROMB HAEMOSTASIS, V45, P200
[8]   Recombinant FVIIa in the treatment of bleeding in acquired hemophilia [J].
Guerin, V ;
Chossat, I ;
Dutronc, H ;
Dubreuil, M ;
Valentin, F .
AMERICAN JOURNAL OF HEMATOLOGY, 2002, 70 (04) :333-333
[9]  
HAUSER I, 1995, THROMB HAEMOSTASIS, V73, P1
[10]  
HAUSER I, 1993, WIEN KLIN WOCHENSCHR, V105, P355